Filtrer

Type
Date de publication
Langue

Documents Procyshyn, Ric M. (Ric Michael) 3 résultats

Filtrer
Sélectionner : Tous / Aucun
Q
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- 454 p.
Cote : QV 77.2 C641 2019

Psychotropes - Guides, manuels, etc.

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
• Independent, unbiased, up-to-date
• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
• Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
• Potential interactions and side effects summarized in comparison charts
• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• Clearly written patient information sheets available for download as printable PDF files

New in this edition
• Antidepressants chapter includes new section on esketamine (Spravato), recently approved for treatment-resistant depression; also updates to antidepressant use in pregnancy and SPARI drug interactions
• Antipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategies
• Pharmacogenomics chapter fully revised with expanded dose adjustment recommendations
• Chart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettes
• Unapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazosin), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene)
• Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazine
• New formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, Aristada, Austedo, Cotempla XR-ODT, Fanatrex FusePaq, Foquest, Ingrezza, Jornay PM, Mydayis, Nuplazid, Sublocade, Zelapar
This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- 362 p. : ill.
Cote : QV 77.2 C640 2014

Psychotropes ; Pharmacologie pédiatrique ; Maladies mentales - Chimiothérapie

Many psychotropic drugs are used to treat childhood and adolescent mental illness on the basis of efficacy in adults, despite not being currently approved for use in the young. The lack of approval does not necessarily reflect lack of safety or efficacy, but it does reflect a lack of controlled studies. The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choice for younger patients :
Independent, unbiased
Unique comparison charts (dosages, side effects, pharmacokinetics, interactions…) that allow you to see at a glance which medication is the most suitable for each patient
Instantly recognizable icons and full color throughout
Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference
Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations
Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Health Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions... All you need to know for each class of drug!Many psychotropic drugs are used to treat childhood and adolescent mental illness on the basis of efficacy in adults, despite not being currently approved for use in the young. The lack of approval does not necessarily reflect lack of safety or efficacy, but it does reflect a lack of controlled studies. The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choice for younger patients :
Independent, unbiased
Unique comparison charts (dosages, side effects, pharmacokinetics, interactions…) that allow you to see at a glance which medication is the most suitable for each patient
Instantly recognizable icons and full color throughout
Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference
Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations
Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Health Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions... All you need to know for each class of drug!

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y

Cote : QV 77.9 P964c DVD 2011
Conférence du 17 novembre 2011
Introduction en français, conférence en anglais.
Public cible : Personnel médical

Neuroleptiques ; Psychopharmacologie

... Lire [+]

Favoris Imprimer